Diabetes mellitus most commonly occurs after the neonatal period and results from complex
interactions between both environmental and incompletely penetrant genetic factors …

Young patients with diabetes, their families, and their diabetes care providers continue to be
faced with the challenge of striving to maintain blood glucose levels in the near-normal …

Thirty years after its introduction, the use of continuous subcutaneous insulin infusion (CSII)
keeps increasing, especially among children and adolescents. The technique, when used …

Neonatal diabetes mellitus (DM) is defined by the onset of persistent hyperglycemia within
the first six months of life but may present up to 12 months of life. A gene mutation affecting …

Diabetes mellitus and impaired fasting glucose associated with single gene mutations are
less rare than previously thought and may account for more than 6% of patients attending a …

Neonatal diabetes mellitus is a rare genetic disease that affects 1 in 90,000 live births. The
start of the disease is often before the baby is 6 months old, with rare cases of onset …

Increasing evidence points to the importance of achieving low blood glucose variability and
also a low hemoglobin A1c (HbA1c) to prevent diabetic late complications. Continuous …

Permanent neonatal diabetes mellitus is a rare disorder known to be caused by activating
mutations in KCNJ11 or ABCC8, inactivating mutations in INS, or very rarely in GCK or …

Aims Neonatal diabetes mellitus (NDM) is a rare disorder, and guidance is limited regarding
its optimal management. We reviewed insulin usage in NDM, with a focus on continuous …

Aims Neonatal diabetes mellitus (NDM) is defined as hyperglycemia and impaired insulin
secretion with onset within 6 months of birth. While rare, NDM presents complex challenges …